Human apolipoprotein A-I gene promoter mutation influences plasma low density lipoprotein cholesterol response to dietary fat saturation

Atherosclerosis

Volumn 137, Issue 2, 1998, Pages 367-376

  Mata, Pedro ^a   Lopez Miranda, Jose ^b   Pocovi, Miguel ^c   Alonso, Rodrigo ^a   Lahoz, Carlos ^a   Marin, Carmen ^b   Garces, Carmen ^a   Cenarro, Ana ^c   Perez Jimenez, Francisco ^b   De Oya, Manuel ^a   Ordovas, Jose M ^d  

^a Hospital UniversitarioFundación Jiménez Díaz   (Spain)

^b HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^c UNIVERSITY OF ZARAGOZA   (Spain)

^d TUFTS UNIVERSITY   (United States)

Author keywords

Apolipoprotein A I; Diet; Gene polymorphism; Gene environment interaction; High density lipoproteins; Low density lipoproteins; Promoter

Indexed keywords

APOLIPOPROTEIN A1; FATTY ACID; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MONOUNSATURATED FATTY ACID; POLYUNSATURATED FATTY ACID; TRIACYLGLYCEROL;

ADULT; ARTICLE; CORONARY ARTERY DISEASE; FAT INTAKE; FEMALE; GENE MUTATION; GENETIC POLYMORPHISM; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; SEX DIFFERENCE; SMOKING;

ADULT; APOLIPOPROTEIN A-I; CHOLESTEROL, LDL; DIETARY FATS; DNA; DNA PRIMERS; FATTY ACIDS, MONOUNSATURATED; FATTY ACIDS, UNSATURATED; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERCHOLESTEROLEMIA; MALE; MIDDLE AGED; MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POSTPRANDIAL PERIOD; PROMOTER REGIONS (GENETICS); TRIGLYCERIDES;

EID: 17144445460     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(97)00265-7     Document Type: Article

References (43)

1. Exp Panel High Blood Chol Adults Summary of the second report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel II). J Am Med Assoc. 269:1993;3015.
2. Grundy S.M. Comparison of monounsaturated fatty acids and carbohydrates for lowering cholesterol. N Engl J Med. 314:1986;745.
3. Mata P., Garrido J.A., Ordovas J.M.et al. Effect of dietary monounsaturated fatty acids on plasma lipoproteins and apolipoproteins in women. Am J Clin Nutr. 56:1992;77.
4. Jacobs D.R., Anderson J.T., Hannan P., Keys A., Blackburn H. Variability in individual serum cholesterol response to change in diet. Arteriosclerosis. 3:1983;349.
5. Clarkson TB, McMahan MR. Individual differences in the response of serum cholesterol to change in diet: animal studies. In: Lauer RM, Shekelle RB, editors. Childhood Prevention of Atherosclerosis and Hypertension. New York: Raven Press, 1980:127-135.
6. Fielding C.J., Shore V.G., Fielding P.E. A protein co-factor of lecithin:cholesterol acyltransferase. Biochem Biophys Res Commun. 46:1972;1493.
7. Reichl D., Miller N.E. Pathophysiology of reverse cholesterol transport: Insights from inherited disorders of liporptein metabolism. Arteriosclerosis. 9:1989;785.
8. Karathanasis S.K. Apolipoprotein multigene family: tandem organization of human apolipoprotein A-I, C-III and A-IV genes. Proc Natl Acad Sci USA. 82:1985;6374.
9. Blangero J., MacCluer J.W., Kammerer C.M., Mott G.E., Dyer T.D., McGill H.C. Jr. Genetic analysis of apolipoprotein A-I in two dietary environments. Am J Hum Genet. 47:1990;414.
10. Xu C.-F., Boerwinkle E., Tikkanen M.J., Huttunen J.K., Humphries S.E. Genetic variation at the apolipoprotein gene loci contribute to response of plasma lipids to dietary change. Genet Epidemiol. 7:1990;261.
11. Wojclechowski A.P., Farral M., Cullen P.et al. Familial combined hyperlipidemia linked to the apolipoprotein AI-CIII-AIV gene cluster on chromosome 11q23-q24. Nature. 349:1991;161.
12. Tybjærg-Hansen A., Nordestgaard B.G., Gerdes L.U., Færgeman O., Humphries S.E. Genetic markers in the apo AI-CIII-AIV gene cluster for combined hyperlipidemia, hypertriglyceridemia, and predisposition to atherosclerosis. Atherosclerosis. 100:1993;157.
13. Angotti E., Mele E., Costanzo F., Avvedimento E.V. A polymorphism (G→A transition) in the -78 position of the apolipoprotein A-I promoter increases transcription efficiency. J Biol Chem. 269:1994;17371.
14. Pagani F., Sidoli A., Giudici G.A., Barenghi L., Vergani C., Baralle F.E. Human apolipoprotein A-I gene promoter polymorphism: Association with hyperalphalipoproteinemia. J Lipid Res. 31:1990;1371.
15. Jeenah M., Kessling A., Miller N., Humphries S.E. G to A substitution in the promoter region of the apolipoprotein AI gene is associated with elevated serum apolipoprotein AI and high density lipoprotein cholesterol concentrations. Mol Biol Med. 7:1990;233.
16. Paul-Hayase H., Rosseneu M., Robinson D., Van Bervliet J.P., Deslypere J.P., Humphries S.E. Polymorphisms in the apolipoprotein (apo) AI-CIII-AIV gene cluster: Detection of genetic variation determining plasma apo AI, apo CIII and apo AIV concentrations. Hum Genet. 88:1992;439.
17. Pagani F., Giudici G.A., Baralle F.E., Vergani C. Association of a polymorphism in the apoA-I gene promoter with hyperalphalipoproteinemia. Eur J Epidemol. 8(Suppl 1):1992;54.
18. Saha N., Tay J.S.H., Low P.S., Humphries S.E. Guanidine to adenine (G/A) substitution in the promoter region of the apolipoprotein AI gene is associated with elevated serum apolipoprotein AI levels in Chinese non-smokers. Genet Epidemiol. 11:1994;255.
19. Talmud P.J., Ye S., Humphries S.E. Polymorphism in the promoter region of the apolipoprotein AI gene associated with differences in apolipoprotein AI levels: The European Atherosclerosis Research Study. Genet Epidemiol. 11:1994;265.
20. Tuteja R., Tuteja N., Melo C., Casari G., Baralle F.E. Transcription efficiency of human apolipoprotein A-I promoter varies with naturally occurring A to G transition. FEBS Lett. 304:1992;98.
21. Smith J.D., Brinton E.A., Breslow J.L. Polymorphism in the human apolipoprotein A-I gene promoter region. Association of the minor allele with decreased production rate in vivo and promoter activity in vitro. J Clin Invest. 89:1992;1796.
22. Lopez-Miranda J., Ordovas J.M., Espino A.et al. Influence of mutation in human apolipoprotein A-1 gene promoter on plasma LDL cholesterol response to dietary fat. Lancet. 343:1994;1246.
23. Lopez-Miranda J., Ordovas J.M., Ostos M.A.et al. Effects of the human apolipoprotein A-I promoter G/A mutation on postprandial lipoprotein metabolism (Abstract). Circulation. 92:1995;745.
24. Hixson J.E., Vernier D.T. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res. 31:1990;545.
25. Tenkanen H. Genotyping of apolipoprotein A-IV by digestion of amplified DNA with restriction endonuclease Fn4H1: use of a tailored primer to abolish additional recognition sites during the gene amplification. J Lipid Res. 32:1991;545.
26. Hegsted D.M., Ausman L.M., Johnson J.A., Dallal G.E. Dietary fat and serum lipids: An evaluation of the experimental data. Am J Clin Nutr. 57:1993;875.
27. Papazafiri P., Ogami K., Ramji D.P.et al. Promoter elements and factors involved in hepatic transcription of the human apoA-I gene positive and negative regulators bind to overlapping sites. J Biol Chem. 266:1991;5790.
28. Civeira F., Pocovi M., Cenarro A., Garces C., Ordovas J.M. Adenine for guanine substitution -78 base pairs to the apolipoprotein(APO) A-I gene: relation with high density lipoprotein cholesterol and apoA-I concentrations. Clin Genet. 44:1993;307.
29. Barre D.E., Guerra R., Verstraete R., Wang Z., Grundy S.M., Cohen J.C. Genetic analysis of a polymorphism in the human apolipoprotein A-I gene promoter: Effect on plasma HDL-cholesterol levels. J Lipid Res. 35:1994;1292.
30. Minnich A., DeLangavant G., Lavigne J., Roederer G., Lussier-Cacan S., Davignon J. G→A substitution at position -75 of the apolipoprotein A-I gene promoter - Evidence against a direct effect on HDL cholesterol levels. Arterioscler Thromb Vasc Biol. 15:1995;1740.
31. Clifton P.M., Nestel P.J. Influence of gender, body mass index, and age on response of plasma lipids to dietary fat plus cholesterol. Arterioscler Thromb. 12:1992;955.
32. Denke M.A. Review of human studies evaluating individual dietary responsiveness in patients with hypercholesterolemia. Am J Clin Nutr. 62:1995;471S.
33. Howard B.V., Hannah J.S., Heiser C.C., Jablonski K.A. Effects of sex and ethnicity on responses to a low fat diet: a study of African Americans and whites. Am J Clin Nutr. 62:1995;488S.
34. Ordovas J.M., Lopez-Miranda J., Mata P., Perez-Jimenez F., Lichtenstein A.H., Schaefer E.J. Gene-Diet interaction in determining plasma lipid response to dietary intervention. Atherosclerosis. 118:1995;S11.
35. Pouliot M.C., Despres J.-P., Moorjani S., Lupien P.J., Tremblay A., Bouchard C. Apolipoprotein E polymorphism alters the association between body fatness and plasma lipoproteins in women. J Lipid Res. 31:1990;1023.
36. Dreon D.M., Fernstrom H.A., Miller B., Krauss R.M. Apolipoprotein E isoform phenotype and LDL subclass response to a reduced-fat diet. Arterioscler Thromb Vasc Biol. 15:1995;105-111.
37. Sigurdsson G. Jr., Gudnason V., Sigurdsson G., Humphries S.E. Interaction between a polymorphism of the Apo A-I promoter region and smoking determines plasma levels of HDL and Apo A-I. Arterioscler Thromb. 12:1992;1017.
38. Pan X.M., Staprans I., Read T.E., Rapp J.H. Cigarette smoke alters chylomicron metabolism in rats. J Vasc Surg. 18:1993;161.
39. McCall M.R., van den Berg J.J.M., Kuypers F.A.et al. Modification of LCAT activity and HDL structure: new links between cigarette smoke and coronary heart disease risk. Arterioscler Thromb. 14:1994;248.
40. Von Eckardstein A., Funke H., Schulte M., Erren M., Schulte H., Assmann G. Nonsynonymous polymorphic sites in the apolipoprotein (apo) A-IV gene are associated with changes in the concentration of apo B- and apo A-I-containing lipoproteins in a normal population. Am J Hum Genet. 50:1992;1115.
41. Mata P. Ordovas JM, Lopez-Miranda J, Lichtenstein AH, Clevidence B, Judd JT, Schaefer EJ. Apolipoprotein A-IV phenotype affects diet induced plasma low density lipoprotein cholesterol lowering. Arterioscler Thromb. 14:1994;884.
42. McCombs R.J., Marcadis D.E., Ellis J., Weinberg R.B. Attenuated hypercholesterolemic response to a high-cholesterol diet in subjects heterozygous for the apolipoprotein A-IV-2 allele. N Engl J Med. 331:1994;706.
43. Jansen S., Lopez-Miranda J., Salas J., Ordovas J.M., Castro P., Marin C., Ostos M.A., Lopez-Segura F., Jimenez-Pereperez J.A., Blanco A., Perez-Jimenez F. Effect of 347-Serine mutation in apolipoprotein A-IV on plasma lipid response to dietary fat. Arterioscler Thromb Vasc Biol. 17:1997;1532.